Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects by L. Soldati et al.
Soldati et al. Journal of Translational Medicine 2014, 12:34
http://www.translational-medicine.com/content/12/1/34RESEARCH Open AccessRelevance of Mediterranean diet and glucose
metabolism for nephrolithiasis in obese subjects
Laura Soldati1*, Simona Bertoli2, Annalisa Terranegra1, Caterina Brasacchio1, Alessandra Mingione1, Elena Dogliotti1,
Benedetta Raspini1, Alessandro Leone2, Francesca Frau1, Laila Vignati2, Angela Spadafranca2, Giuseppe Vezzoli3,
Daniele Cusi1 and Alberto Battezzati2Abstract
Background: Nephrolithiasis is more frequent and severe in obese patients from different western nations. This
may be supported by higher calcium, urate, oxalate excretion in obese stone formers. Except these parameters,
clinical characteristics of obese stone formers were not extensively explored.
Aims: In the present paper we studied the relationship between obesity and its metabolic correlates and
nephrolithiasis.
Materials and methods: We studied 478 Caucasian subjects having BMI ≥ 25 kg/m2. The presence of
nephrolithiasis, hypertension, diabetes mellitus and metabolic syndrome were noted. They underwent
measurements of anthropometry (BMI and waist circumference, body composition), serum variables (fasting
glucose, serum lipids and serum enzymes) and Mediterranean diet (MedDiet) nutritional questionnaire.
Results: 45 (9.4%) participants were stone formers. Subjects with high serum concentrations of triglycerides
(≥150 mg/dl), fasting glucose (> 100 mg/dl) and AST (>30 U/I in F or >40 U/I in M) were more frequent among
stone formers than non-stone formers.
Multinomial logistic regression confirmed that kidney stone production was associated with high fasting glucose
(OR = 2.6, 95% CI 1.2-5.2, P = 0.011), AST (OR = 4.3, 95% CI 1.1-16.7, P = 0.033) and triglycerides (OR = 2.7, 95% CI 1.3-
5.7, P = 0.01).
MedDiet score was not different in stone formers and non-stone formers. However, stone formers had a lower
consumption frequency of olive oil and nuts, and higher consumption frequency of wine compared with
non-stone formers.
Conclusions: Overweight and obese stone formers may have a defect in glucose metabolism and a potential liver
damage. Some foods typical of Mediterranean diet may protect against nephrolithiasis.Introduction
Dietary habit is generally acknowledged as a determinant in
the pathogenesis of nephrolithiasis [1]. In this regard, many
studies have shown a correlation between obesity and
nephrolithiasis occurrence and severity, but were unable to
clarify the mechanism leading to these relationships [2]. In
addition, clinical pattern of obese stone formers has not
been extensively studied. Nephrolithiasis risk could be exac-
erbated in obese subjects, because urine defects predispos-
ing to stones are more striking in these patients. Higher* Correspondence: laura.soldati@unimi.it
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pH and citrate excretion have been described in patients
with metabolic syndrome and high body mass index (BMI)
[3-6]. Insuline resistance and hyperinsulinemia were ob-
served in overweight patients and may contribute to in-
crease calcium and post-prandial oxalate excretion, thus,
favoring calcium-oxalate stone formation [7].
Therefore, to clarify the relationship between obesity
and nephrolithiasis, we analyzed in the present work the
metabolic and clinical characteristics of obese and over-
weight subjects with a stone history and compared them
with those without stones. We also analyzed the adher-
ence of these subjects to Mediterranean diet with aLtd. This is an Open Access article distributed under the terms of the Creative
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diet by stone formers and non-stone formers with high
BMI.
Materials and methods
Sample
Four hundred and ninety subjects (M/F 155/335, age 49 ±
10.3 yrs, Body weight 86.1 ± 16.42 kg, BMI 31.5 ± 4.99
kg/m2) were recruited among patients who attended the
International Center for the Assessment of Nutritional Sta-
tus (ICANS), University of Milan. Eligible for the study
were Caucasian subjects of both genders, aged between 30
and 70 years and having BMI ≥ 25 kg/m2. They had to have
no endocrine, neoplastic and inflammatory diseases, with
the exception of type 2 diabetes mellitus and arterial hyper-
tension, and their serum creatinine had to be ≤ 1.25 mg/dl.
They had to take no chronic therapy with the exception of
therapy for arterial hypertension, dyslipidemia and oral an-
tidiabetics. Participants were studied for their nutritional
status, blood variables and abdominal sonography. Blood
variables were measured in participants after an overnight
fast.
The presence of kidney stones was assessed by a self-
questionnaire including 12 multiple-choice questions on
kidney stones history based on sonographic exams and
previous symptoms. The study protocol was approved
by the Ethical Committee of the Milan University. All
subjects gave informed consent to participate to the
study.
Nutritional status assessment
Anthropometric measurements
BMI (kg/m2) was calculated from body weight (kg) and
height (m) using the formula: BMI =weight/height2. Waist
and hip circumferences were measured as proposed by
Lohman et al. [8] and waist-to-hip ratio was calculated to
assess abdominal fatness. The same operator measured
these variables according to conventional criteria and pro-
cedures [8]. Patients with BMI > 30 kg/m2 were defined as
obese. Patients with BMI between 25 and 30 kg/m2 were
defined as overweight.
Ultrasound evaluation
Abdominal ultrasonography was performed with Logiq 3
Pro with a 3.5 MHz convex-array probe and 7.5 MHz
linear probe. We measured the subcutaneous abdominal
tissue as the distance between the epidermidis and exter-
nal face of the rectus abdominis muscle and the visceral
abdominal tissue width as the distance between the an-
terior wall of the aorta and the posterior surface of the
rectus abdominis muscle measured above the umbilicus
at the xiphoumbilical line [9]. The intra-examination co-
efficient of variation of the method was 0.8%.Clinical and biochemical parameters
The use of medications for the treatment of hyperten-
sion, diabetes and dyslipidemia was investigated.
Blood pressure was measured according to JNC-7
guidelines [10]. The hypertension diagnosis was based
either on blood pressure measurements during clinical
examination and subsequently confirmed in the follow-
ing weeks, or on patients’ history and use of antihyper-
tensive drugs.
Creatinine, uric acid, glucose, alanine transaminase
(ALT), aspartate transaminase (AST) and γglutamyl trans-
peptidase (γGT), TSH, triglycerides, cholesterol, LDL, HDL
were measured in serum.
Mediterranean dietary pattern
Adherence to MedDiet pattern was assessed using a vali-
dated 14-item questionnaire with multiple-choice de-
signed for this purpose [11]. Considered items were:
olive oil (2 items), vegetables, fruits, wine, red meat, fish,
sugar drinks, butter, legumes, backed products, white
meat, nuts and sofrito (sauce made with tomato and
onion, leek, or garlic and simmered with olive oil). For
each answer was attributed a score from 0 to 14. Sub-
jects with score ≥9 were considered to comply with
MedDiet according to the median value as used in ana-
lyses of the PREDIMED group [12]. The questionnaire
has been considered valid only when all 14 items were
completed.
Statistical analysis
Continuous variables were expressed in the text as mean ±
standard deviation and compared by one-way analysis of
variance (ANOVA) in stone formers and stone free patients
and Tuckey test for comparisons between groups. Distribu-
tion of discrete variables was assessed using chi-square.
The association of variables with nephrolithiasis was tested
by multinomial logistic regression including sex, BMI (3
groups), total cholesterol, fasting glucose, HDL, triglycer-
ides and blood pressure (2 groups). Odds ratio (OR) with
95% confidence interval (95% CI) was calculated. Statistical
analysis was two tailed and was conducted at a 0.05 level. It
was performed with SPSS 21 statistical package.
Results
Clinical variables
All 490 participants to the study had BMI ≥ 25 kg/m2.
Forty-five participants were stone formers (9.2%), whereas
445 had no history of kidney stones. Among non-stone
former 30 received therapy for dyslipidemia, 99 for hyper-
tension and 9 for diabetes. Among stone former 7 received
therapy for dyslipidemia, 16 for hypertension and 3 for dia-
betes. Stone formers were older than non-stone formers
and had higher serum concentrations of triglycerides. A
slight increase of fasting glucose and AST were also found
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(Table 2), subjects with high serum concentrations of tri-
glycerides, fasting glucose and AST were more frequently
found in stone formers than stone-free subjects.
Two hundred and fifty-seven subjects were obese (BMI ≥
30 kg/m2): 9.3% of them were stone formers (n = 24). Two
hundred and thirty-three subjects were overweight: similar
to obese subjects, 9.0% of them were stone formers
(n = 21). In both obese and overweight subjects, stone for-
mers were older than non-stone formers.
Multinomial logistic regression confirmed that kidney
stone production was associated with high fasting glu-
cose (OR = 2.6, 95% CI 1.2-5.2, P = 0.011), AST (OR =
4.3, 95% CI 1.1-16.7, P = 0.033) and triglycerides (OR =
2.7, 95% CI 1.3-5.7, P = 0.01). A second multinomial lo-
gistic regression model also adjusted for VAT and SAT
was used to investigate the association between kidney
stone and abdominal obesity, confirming that kidneyTable 1 Serum variables in stone formers and non-stone
formers
Stone
formers
Non-stone
formers
N (M/F) 45 (18/27) 445 (137/308)
Age (years) 53 ± 10.9* 48 ± 10.2
Body weight (kg) 86.6 ± 15.01 86 ±16.57
BMI (kg/m2) 31.8 ± 5.12 31.5 ± 4.98
Total serum cholesterol (mg/dl) 211 ± 39.5 214 ± 38.4
Serum HDL (mg/dl) 53 ± 14.5 56 ± 14.4
Serum LDL (mg/dl) 133 ±39.3 138 ± 33.4
Serum triglycerides (mg/dl) 146 ± 110.5¶ 110 ± 67.1
Fasting serum glucose (mg/dl) 102 ± 21.5† 96 ± 14.2
Serum uric acid (mg/dl) 5.2 ± 1.30 5.1 ± 1.39
Serum creatinine (mg/dl) 0.79 ± 0.186 0.77 ± 0.16
Serum TSH (ng/ml) 2.35 ± 1.268 2.23 ±1.49
Serum γGT (U/I) 39 ± 36.1 30 ± 32.7
Serum AST (U/I) 25 ± 12.6 † 21 ± 8.1
Serum ALT (U/I) 30 ± 19.6 26 ± 15.9
Waist circumference (cm) 105 ± 12.0 101 ± 12.7
Arm circumference (cm) 33 ± 4.4 34 ± 4.1
Wrist circumference (cm) 17 ± 1.4 17 ± 1.8
Subcutaneous abdominal tissue
(cm)
3.2 ± 1.19 3.3 ± 1.12
Visceral abdominal tissue (cm) 6.8 ± 2.52 6.2 ± 2.58
Systolic blood pressure (mmHg) 132 ± 14.4 129 ± 13.7
Diastolic blood pressure (mmHg) 81 ± 9.3 80 ± 9.1
MedDiet score 7 ± 1.55 6.75 ± 1.63
*p = 0.002.
¶p = 0.044.
†p < 0.06.stone production was associated with high fasting glu-
cose and triglycerides (data not shown).
The number of stone formers was higher in diabetic
than non-diabetes patients (n = 6 [22.2% of diabetic pa-
tients] vs n = 39 [8.4% of non-diabetic patients], chi
square = 5.8, DF = 1, p = 0.016). Conversely, stone disease
was not associated with arterial hypertension (n = 15
[12.6% of hypertensive patients vs n = 30 [8.1% of
normotensive patients]).
The analysis of non-diabetic subjects (n = 463) confirmed
that stone formers were older than stone-free subjects (51
± 10.3 vs 48 ± 10 yrs, p = 0.037). The number of patients
with high fasting serum glucose (n = 16 [41% of stone for-
mers] vs n = 97 [23.7% of stone free patients]; p = 0.019),
AST (n = 6 [15.3%] vs n = 25 [5.9%]; p = 0.015) and trygli-
cerides (n = 16 [41%] vs n = 75 [17.7%]; p = 0.001) was
higher in non-diabetic stone formers than stone-free
subjects.
Among normotensive subjects (PA ≤ 130/80 mmHg, n =
371), stone formers were older than stone-free subjects
(52 ± 11.2 [n = 30] vs 46 ± 9.7 [n = 341] yrs, p = 0.001).
Subjects with high fasting serum glucose (n = 16
[53.3%], vs n = 76 [22.2%]; p = 0.001), AST (n = 6 [20%]
vs n = 22 [6,5%]; p = 0.007) and tryglicerides (n = 13
[43.3%] vs n = 60 [17.6%]; p = 0.001) were more frequent
in stone formers than stone free subjects.
The analysis of normotensive and non-diabetic subjects
(n = 357) again showed that stone formers more frequently
had high fasting serum glucose (n = 13 [48.1%], vs n = 66
[20%]; p = 0.001), AST (n = 5 [18.5%] vs n = 19 [5.8%]; p =
0.01) and tryglicerides (n = 12 [44.4%] vs n = 56 [17%]; p =
0.001).Mediterranean diet
Mediterranean diet adherence was evaluated with a specific
questionnaire. In our population n = 75 subjects were ad-
herent to Mediterranean diet (Medscore ≥9) with a mean
score of 6.8 ± 1.62. MedDiet score was not different in
stone formers and subjects with no stone. However, the
analysis of food frequency in Medscore questionnaire
showed that stone formers had lower consumption fre-
quency of olive oil and nuts, but higher consumption of
wine compared with stone-free subjects (Table 3). Multi-
nomial regression analysis observed that decreased risk of
stone was associated with olive oil consumption whereas it
increased in association with wine consumption (Table 4).
Considering only subjects without diabetes (n = 460), it
was confirmed that stone formers consumed lower olive oil
and nuts and greater quantity of wine compared with
stone-free subjects: 10 (25.6%) stone formers vs 176 (41.5%)
stone-free subjects consumed ≥4 spoons of olive oil in a
day (p = 0.05); 23 (59%) stone formers and 130 (30.7%)
stone-free subjects drank ≥7 glasses in a week (p = 0.001);
Table 2 Frequency of subjects with alterated values of
the explored variables in subjects with high BMI
distinguished in stone formers and non-stone formers
Stone formers
N (%)
Non-stone formers
N (%)
Subject count 45 445
Sex (M/F) 18/27 137/308
BMI > 30 kg/m2 24 (53.3) 233 (52.4)
Total serum cholesterol
>200 mg/dl
27 (60) 276 (62.1)
Serum HDL <50 mg/dl in
F or <40 mg/dl in M
31 (68.9) 339 (76.3)
Serum triglycerides
>150 mg/dl
17 (37.7)‡ 80 (17.9)
Fasting serum glucose
>100 mg/dl
22 (48.8)* 121 (27.2)
Serum gGT > 24 U/I in F
or >30 U/I in M
19 (45.2) 148 (36.5)
Serum AST >30 U/I in F
or >40 U/I in M
7 (15.5)† 28 (6.3)
Serum ALT >35 U/I in F
or >40 U/I in M
11 (24.4) 71 (16)
Waist circumference >80 cm
in F or >92 cm in M
43 (95.6) 426 (95.7)
Subcutaneous abdominal
tissue >4 cm
10 (22.2) 99 (22.9)
Visceral abdominal tissue >4 cm 40 (88.9) 346 (77.8)
Systolic blood pressure
>130 mmHg
16 (35.5) 134 (30.1)
Diastolic blood pressure
>85 mmHg
13 (28.9) 84 (18.9)
MedDiet score≥ 9 8 (17.8) 67 (15.1)
‡p = 0.003.
*p = 0.004.
†p = 0.015.
Table 3 Analysis of food frequency in Medscore
questionnaire in stone formers and non-stone formers
Stone formers
N (%)
Non-stone
formers N (%)
N (M/F) 45 445
Use of olive oil as main culinary
lipid
45 (100) 443 (97.3)
Olive oil≥ 4 tablespoons 11 (24.4) 188 (42.5)*
Vegetables≥ 2 servings/day 28 (62.2) 252 (56.6)
Fruits ≥3 servings/day 8 (17.8) 75 (16.9)
Red/processed meats <1/day 34 (75.5) 293 (65.8)
Butter, cream, margarine <1/day 45 (100) 431 (96.8)
Soda drinks <1/day 38 (84.4) 377 (84.7)
Wine glasses ≥7/week 27 (60) 138 (31)†
Legumes ≥3/week 2 (4.4) 17 (3.8)
Fish/seafoods ≥3/week 2 (4.4) 30 (6.7)
Commercial sweets and
confectionery <3/week
30 (66.7) 236 (53)
Free nuts ≥1/week 0 (0) 51 (11.5)*
Poultry more than red meats 29 (64.4) 259 (58.2)
Use of sofrito sauce ≥2/week 23 (51.1) 245 (55.1)
Items included in the MedScore questionnaire. Between parentheses there is
the response showing adherence to Mediterranean diet.
Number (percentage) of subjects satisfying criteria of Mediterranean diet for
each item [11,12].
*p = 0.019.
†p = 0.001.
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nuts (p = 0.028).
Discussion
The present work analyzes the metabolic pattern of over-
weight and obese stone formers (BMI ≥ 25 kg/m2) to find
differences related to the kidney stone disease. Contrarily to
previous studies, high body weight was not positively asso-
ciated with kidney stones in our patients [13-15]. We found
that the serum concentration of AST, fasting glucose and
triglycerides were higher in stone formers, suggesting that
stone production may be associated with an altered hand-
ling of glucose and triglycerides and with a liver disorder.
Abdominal obesity (both VAT and SAT components) seems
not to be associated with stone production. Insuline resist-
ance and hyperinsulinemia have been reported in subjects
with high BMI [16] and, although not explored in our pa-
tients, these defects could sustain the observed serum alter-
ation of glucose and triglycerides. Iperinsulinemia maycontribute to hyperexcretion of calcium and oxalate, but
also decrease urine pH by inhibition of ammoniagenesis in
proximal tubular cells, thus predisposing patients to uric
acid stones [3]. From a metabolic point of view, triglycer-
ides and glucose are important energy reserve and the in-
crease of their serum levels may favor the raise of visceral
fat, while products of their catabolism may increase the acid
load for the body that may decrease citrate excretion [2,3].
Also, a diet rich in animal fats and proteins has been in-
volved in kidney stone production because it causes acid
overload and urine acidification [17-19].
The increase of serum AST might be expression of a liver
damage that could be supported by a fat accumulation
leading to the condition of hepatic steatosis caused by un-
healthy eating habits in overweight-obese patients. An ab-
normal visceral and subcutaneous fat accumulation was
found to be associated with hepatic steatosis in subjects
without nephrolithiasis [20]. However, the higher consump-
tion of red wine among the stone formers may have influ-
enced the outcome. Therefore, further studies confirming
the association between kidney stones and abnormal liver
enzymes, are needed.
Subjects included in the present study showed low
adherence to Mediterranean Diet without difference
coupled to nephrolithiasis. The analysis of single
Table 4 Multinomial regression analysis of olive oil and wine consumption in stone formers and non-stone formers
Score 1 <1 spoon/day Score 2 1-3 spoons/day Score 3 or 4 ≥4 spoons/day
Olive oil
Stone formers 6 (13.3) 28 (62.2) 11 (24.4)
Non-stone formers 33 (7.5) 221 (50) 188 (42.6)
OR 1 0.7 0.32
95% CI 0.3-1.8 0.1–0.9
p 0.46 0.036
Score 1 Score 2 Score 3 Score 4
No consumption 1–2 glasses/week 3–7 glasses/week >7 glasses/week
Wine
Stone formers 13 (30.2) 4 (9.3) 16 (37.2) 10 (23.3)
Non-stone formers 189 (42.9) 115 (26.1) 83 (18.8) 54 (12.2)
OR 1 0.51 2.8 2.7
95% CI 0.2–1.6 1.3–6.1 1.1–6.5
p 0.24 0.009 0.027
Olive oil and wine consumption was quantified according to the criteria adopted by the MedScore questionnaire that attributed a score between 0 and 4 to these
item. Due to the low patient number, the score 3 and 4 of olive oil consumption were taken together in this multinomial regression analysis.
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showed that the consumption of olive oil and nuts
were lower in stone formers, suggesting a possible
higher intake of animal fats in these patients indu-
cing an urine environment that predisposes to kid-
ney stone production as previously reported [17-19].
Positive effects of olive oil were evidenced in previ-
ous studies observing the association at its dietary
use with high HDL serum levels and low blood
pressure, LDL serum levels and obesity [12,21-23].
Although these advantages, its potential protective
effect against nephrolithiasis in subjects with high
BMI remains unexplained. Future prospective studies are
needed to better understand the protective role of olive oil
in the pathogenesis of nephrolithiasis. These findings are
consistent with previous prospective surveys analyzing
DASH diet effects in stone forming patients [24,25]. On the
contrary, the negative association of wine with stone risk
has not been previously recorded because prospective sur-
veys showed that wine, similar other beverages, reduces the
risk of stones [26,27]. This discrepancy may be explained
by our choice to study only obese and overweight subjects
and suggests that wine may have different effects on the
lithogenesis according to the patient substrate. Specific
studies are needed to confirm this result in obese subjects.
Similar consideration could be proposed for legumes that
for unknown reason resulted predisposing to stones in our
population.
Limitations of this study are the fact that we could not
distinguish patients with different stone composition
and that the presence of stones was self-reported by
patients. In addition, our study is cross-sectional and not
prospective and therefore it cannot provide anyconclusive causal inference from its findings. Another
limitation of our study is the fact that we did not meas-
ure urine calcium, urate and oxalate, and we did not in-
vestigate the presence of liver steatosis with liver
ultrasonography or biopsy in our patients. However, the
aim of our study was to evaluate parameters of metabol-
ism used in the clinical routine and the attitude to
Mediterranean diet.
In conclusion, our findings suggest that overweight and
obesity could be associated with kidney stones through a
defect in glucose metabolism. Furthermore, obese stone
formers may be characterized by a potential liver damage.
In our knowledge, these alterations have not been previ-
ously described in stone formers. Finally, some foods typical
of Mediterranean diet may protect subjects with high BMI
against the risk of nephrolithiasis.
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